| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10212813 | The American Journal of the Medical Sciences | 2018 | 5 Pages |
Abstract
The TRPG is not only a useful predictor of adverse CV events and all-cause mortality in patients with AF, it may also provide additional prognostic values for CV outcome and all-cause mortality over conventional parameters in such patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Po-Chao MD, PhD, Wen-Hsien MD, Chun-Yuan MD, Wei-Chung MD, Hung-Hao MD, Chee-Siong MD, Hsueh-Wei MD, Tsung-Hsien MD, PhD, Wen-Chol MD, Wen-Ter MD, Sheng-Hsiung MD, Ho-Ming MD,